Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Sex differences in cardiovascular disease risk
Wed January 27th - Doctors often mistake the development of hypertension in women for symptoms of menopause, according to a new analysis. More
Hope for end to melanoma rates growth
Wed January 27th - The growth in melanoma incidence in young adults has “stabilised” this century, suggesting that public health messages may have had some success, according to a new UK study. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...

Cell hope for Huntington's disease

Wednesday June 8th, 2016

A novel form of cell transplant may form a successful cure for Huntington's disease, say researchers from the University of Copenhagen, Denmark.

The team, led by Professor Steven Goldman, examined the effectiveness of transplanting healthy glial cells to prolong life expectancy and alleviate symptoms in mice with Huntington's disease.

Glial cells in the in the central and peripheral nervous systems are not neurons, they play a role in maintaining homeostasis, build myelin sheaths for neurons, and provide other forms of support.

Firstly, the team transplanted glial cells infected with gene mutations of Huntington's disease into healthy mice, and observed that these mice developed symptoms of Huntington's in adulthood. This led the team to believe in a causal link between glial cells and the development of Huntington's disease.

Next, the team transplanted healthy human glial cells into the mice with Huntington's disease, which led to an improvement in the mice's motor and cognitive skills improved. Mice given this treatment also had a longer lifespan.

The team say these results may be of great importance to future treatment of neurological diseases. Details were published in Nature Communications yesterday (7 June).

"It's the first time, we've conducted this type of transplant and the results are both positive and surprising," said Professor Goldman. "It reveals that diseased mice injected with healthy glial cells live longer and their condition improves. This is very promising, and it's only the tip of the iceberg.

"We hope to be able to conduct further research on whether we may be able to improve function and delay progression with glial transplants."

Benraiss, A. et al. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nature Communications 7 June 2016; doi:10.1038/ncomms11758 [abstract]

Tags: Brain & Neurology | Europe | Transplant

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)